Morningside Ventures

Morningside Ventures accounts for 22 tracked companies with verified cap-table data, 22 of which disclose round sizes totalling $2.2B. The median disclosed raise is $93M, and the largest is Gracell Biotechnologies at $520M, ahead of New Amsterdam Pharma ($196M) and Amylyx Pharmaceuticals ($172M).

The names that recur most often on these portfolio cap tables are Morningside Ventures (22 companies), Vivo Capital (2 companies), OrbiMed (2 companies), Lilly Asia Ventures (2 companies), Janus Henderson Investors (2 companies), Forbion (2 companies). By latest disclosed round, the market skews Series C (10), Series A (4), Series B (4), IPO (1).

• Companies tracked: 22
• Disclosed funding total: $2.2B across 22 companies
• Median disclosed raise: $93M
• Largest raise: Gracell Biotechnologies — $520M
• Stage mix: Series C 10 · Series A 4 · Series B 4 · IPO 1
• Most recent dated round: 2026-05-18

Best funded Morningside Ventures companies

1. Gracell Biotechnologies — $520M (latest: IPO)
2. New Amsterdam Pharma — $196M (latest: Series A)
3. Amylyx Pharmaceuticals — $172M (latest: Series C)
4. Hummingbird Bioscience — $125M (latest: Series C)
5. Eko Health — $125M (latest: Series C)
6. ENYO Pharma — $102M (latest: Series C)
7. Accro Bioscience — $100M (latest: Series C)
8. F2G — $100M (latest: Growth)
9. Triastek — $100M (latest: Series B)
10. Virtue Diagnostics — $100M (latest: Series B)
11. Apellis Pharmaceuticals — $93M (latest: Series E)
12. Iyiou Big Health — $75M (latest: Series C)
13. Elysium — $71M (latest: Series C)
14. Immune Regulation — $53M (latest: Series B)
15. Haizhi Wangju Internet Technology — $45M (latest: Series C)

Morningside Ventures — related firms and companies (56)

• Gracell Biotechnologies
• New Amsterdam Pharma
• Amylyx Pharmaceuticals
• Hummingbird Bioscience
• Eko Health
• ENYO Pharma
• Accro Bioscience
• F2G
• Apellis Pharmaceuticals
• Leaf Biotech
• Investors like DCM Ventures
• Investors like 500 Global
• Investors like QED Investors
• Investors like Floodgate
• Elysium
• Cognoa
• Investors like SoftBank Vision Fund
• Investors like Eniac Ventures
• Investors like BoxGroup
• Investors like GSR Ventures
• Haizhi Wangju Internet Technology
• Investors like Morningside Ventures
• Investors like First Round Capital
• Investors like Script Capital
• Investors like Wellington Management
• Investors like Coinbase
• TransThera Biosciences
• Investors like CAVU Consumer Partners
• Investors like Flybridge
• Investors like Thirdbase Capital
• Investors like Western Technology Investment
• Virtue Diagnostics
• Lyvgen Biopharma
• Investors like Blockchain Capital
• Investors like Great Oaks Venture Capital
• Investors like Slow Ventures
• Investors like Irving Investors
• Iyiou Big Health
• Pinteon Therapeutics
• Investors like Correlation Ventures
• Investors like Ridge Ventures
• Investors like Scale Venture Partners
• Investors like Khosla Ventures
• Immune Regulation
• Morningside Ventures co-investors 2026
• Investors like Notable Capital
• Investors like Lightspeed Venture Partners
• Investors like Acre Venture Partners
• Investors like SOSV
• Wellinks (formerly Convexity Scientific)
• Companies backed by Morningside Ventures
• Investors like Amplify Partners
• Investors like Goldman Sachs
• Investors like GIC
• Triastek
• Arctic Vision

Morningside Ventures alternatives · All research reports